Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

March 18, 2016

Statement by Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) US Access Campaign Manager and Legal Policy Adviser 

March 16, 2016

SANAA/BARCELONA, MARCH 16, 2016—Medical teams working for Doctors Without Borders/Médecins Sans Frontières (MSF) in Abs Hospital, Yemen, treated more than 40 patients injured in two deadly airstrikes on a marketplace in Khamis village, Mustaba District, northern Hajja Governorate March 15. Two people died in transit to the hospital, and four patients arrived in critical condition, including an eight-year-old child who was referred to a specialist for neurosurgical care.

March 16, 2016

JUBA—The people of Leer, South Sudan, continue to live in fear, with at least four incidents of rape, looting, and violence recorded this month alone.

In the most recent incident on March 14, 27 civilians—mostly women and children—fled to the Doctors Without Borders/Médecins Sans Frontières (MSF) compound seeking shelter as their houses were looted by a group of men carrying guns.

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

March 10, 2016

PARIS/NEW YORK—Doctors Without Borders/Médecins Sans Frontières (MSF) recently constructed a new site for migrants and refugees who were living in the mud and cold at the Basroch camp in Grande-Synthe, near Dunkirk in northern France. The new camp has the capacity to house 2,500 people, but it is already being threatened with closure by French authorities.

March 09, 2016

New York— A Senate committee voted today to add Zika to the list of diseases eligible for the US Federal Drug Administration (FDA) Priority Review Voucher (PRV) program for neglected diseases, but did not fix major loopholes that make the PRV program for neglected diseases ripe for abuse by pharmaceutical companies.

March 08, 2016
March 04, 2016

"A resolution is a welcome step but only if it shows an unwavering commitment to ensuring that health workers, facilities, and patients never come under attack. Several permanent members of the United Nations Security Council have over recent months been engaged in, or have supported, military activities resulting in destruction of health facilities. Therefore, any new resolution will require states in the security council, notably the permanent members, to lead by example.

March 04, 2016

JUBA, SOUTH SUDAN/BRUSSELS— Doctors Without Borders/Médecins Sans Frontières (MSF) strongly condemns the looting of its medical center in Pibor, in South Sudan’s Jonglei State, during and after heavy fighting from February 23 to 25 that also destroyed large sections of the town, leaving thousands of people in need of aid.

Pages